Oncolytics Biotech Inc (ONC) - Total Liabilities

Latest as of June 2025: CA$13.88 Million CAD ≈ $10.04 Million USD

Based on the latest financial reports, Oncolytics Biotech Inc (ONC) has total liabilities worth CA$13.88 Million CAD (≈ $10.04 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ONC asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Oncolytics Biotech Inc - Total Liabilities Trend (1999–2024)

This chart illustrates how Oncolytics Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Oncolytics Biotech Inc's balance sheet.

Oncolytics Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Oncolytics Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
K2 Capital Acquisition Corporation NASDAQ:KTWO	USA	$272.00K
Punjab Chemicals & Crop Protection Limited NSE:PUNJABCHEM	India	Rs2.93 Billion
Acusensus Ltd AU:ACE	Australia	AU$43.22 Million
Multitude SE LSE:0R4W	UK	€1.43 Billion
Hamat Group Ltd TA:HAMAT	Israel	ILA978.95 Million
Hooker Furniture Corporation NASDAQ:HOFT	USA	$54.12 Million
Golden Long Teng Development Co Ltd TWO:3188	Taiwan	NT$6.95 Billion
PROQR THERAPEUTICS EO-04 F:0PQ	Germany	€63.38 Million

Liability Composition Analysis (1999–2024)

This chart breaks down Oncolytics Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Oncolytics Biotech Inc balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.70	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oncolytics Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oncolytics Biotech Inc (1999–2024)

The table below shows the annual total liabilities of Oncolytics Biotech Inc from 1999 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$14.20 Million ≈ $10.27 Million	+26.18%
2023-12-31	CA$11.26 Million ≈ $8.14 Million	+3.92%
2022-12-31	CA$10.83 Million ≈ $7.84 Million	+10.74%
2021-12-31	CA$9.78 Million ≈ $7.08 Million	+1.97%
2020-12-31	CA$9.59 Million ≈ $6.94 Million	-51.47%
2019-12-31	CA$19.77 Million ≈ $14.30 Million	+127.98%
2018-12-31	CA$8.67 Million ≈ $6.27 Million	-12.13%
2017-12-31	CA$9.87 Million ≈ $7.14 Million	+142.50%
2016-12-31	CA$4.07 Million ≈ $2.94 Million	+50.16%
2015-12-31	CA$2.71 Million ≈ $1.96 Million	-19.69%
2014-12-31	CA$3.37 Million ≈ $2.44 Million	-43.85%
2013-12-31	CA$6.01 Million ≈ $4.35 Million	-17.59%
2012-12-31	CA$7.29 Million ≈ $5.27 Million	+12.10%
2011-12-31	CA$6.50 Million ≈ $4.71 Million	+160.10%
2010-12-31	CA$2.50 Million ≈ $1.81 Million	-43.50%
2009-12-31	CA$4.43 Million ≈ $3.20 Million	-2.38%
2008-12-31	CA$4.53 Million ≈ $3.28 Million	+60.71%
2007-12-31	CA$2.82 Million ≈ $2.04 Million	+1.98%
2006-12-31	CA$2.77 Million ≈ $2.00 Million	+50.15%
2005-12-31	CA$1.84 Million ≈ $1.33 Million	+67.61%
2004-12-31	CA$1.10 Million ≈ $795.19K	+6.22%
2003-12-31	CA$1.03 Million ≈ $748.65K	-26.61%
2002-12-31	CA$1.41 Million ≈ $1.02 Million	-54.78%
2001-12-31	CA$3.12 Million ≈ $2.26 Million	+78.92%
2000-12-31	CA$1.74 Million ≈ $1.26 Million	+638.27%
1999-12-31	CA$236.10K ≈ $170.79K	--

About Oncolytics Biotech Inc

TO:ONC Canada Biotechnology

Market Cap

$1.08 Billion

CA$1.50 Billion CAD

Market Cap Rank

#17939 Global

#587 in Canada

Share Price

CA$14.90

Change (1 day)

+0.00%

52-Week Range

CA$14.90 - CA$14.90

All Time High

CA$18.60